AIO GI Group

AIO Gastrointestinal Oncology (AIO GI Group) is a leading clinical research organization and scientific working group within the German Cancer Society (DKG). The group specializes in the design, coordination, and execution of multicenter clinical trials focused on gastrointestinal cancers, including colorectal, gastric, and pancreatic malignancies. Operating through its administrative arm, AIO-Studien-GmbH, the organization bridges the gap between academic research and the pharmaceutical industry to advance oncological care. Their extensive network of German hospitals and private practices facilitates high-quality data collection that frequently informs international treatment guidelines. The group is recognized for its significant contributions to the development of targeted therapies and immunotherapy combinations in the GI oncology space.